Kidney Function Change and All-Cause Mortality in Denosumab Users with and without Chronic Kidney Disease

Kidney Function Change and All-Cause Mortality in Denosumab Users with and without Chronic Kidney Disease

Denosumab is approved for osteoporosis treatment in subjects with and without chronic kidney disease (CKD). Confirmation is required for its safety, treatment adherence, renal function effect, and mortality in patients with CKD. A retrospective cohort study was conducted to compare new users of deno...

Full description

Bibliographic Details
Main Authors: Ping-Hsun Wu, Ming-Yen Lin, Teng-Hui Huang, Tien-Ching Lee, Sung-Yen Lin, Chung-Hwan Chen, Mei-Chuan Kuo, Yi-Wen Chiu, Jer-Ming Chang, Shang-Jyh Hwang
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Journal of Personalized Medicine
Subjects:
denosumab
adherence
mortality
renal function
chronic kidney disease
Online Access:https://www.mdpi.com/2075-4426/12/2/185

Internet

https://www.mdpi.com/2075-4426/12/2/185

Similar Items